Evome Medical Technologies, Inc. Total Liabilities and Equity
Evome Medical Technologies, Inc. had Total Liabilities and Equity of CAD 48.26 million as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2024-04-16
- 2023-12-31: Liabilities and Equity 48.26M CAD.
- 2023-09-30: Liabilities and Equity 67.89M CAD.
- 2023-06-30: Liabilities and Equity 70.16M CAD.
- 2023-03-31: Liabilities and Equity 52.95M CAD.
| Period end | Liabilities and Equity |
|---|---|
| 2023-12-31 | 48.26M CAD 10-K · filed 2024-04-16 |
| 2023-09-30 | 67.89M CAD 10-Q · filed 2023-11-14 |
| 2023-06-30 | 70.16M CAD 10-Q · filed 2023-08-14 |
| 2023-03-31 | 52.95M CAD 10-Q · filed 2023-05-15 |
| 2022-12-31 | 52.05M CAD 10-K · filed 2024-04-16 |
| 2022-11-30 | 53.66M CAD 10-Q · filed 2023-01-17 |
| 2022-08-31 | 47.94M CAD 10-Q · filed 2022-10-17 |
| 2022-05-31 | 45.42M CAD 10-Q · filed 2022-07-15 |
| 2022-02-28 | 42.68M CAD 10-KT · filed 2023-04-03 |
| 2021-12-31 | 43.54M CAD 10-KT · filed 2023-04-03 |
| 2021-11-30 | 42.98M CAD 10-Q · filed 2022-01-14 |
| 2021-08-31 | 34.78M CAD 10-Q · filed 2021-10-15 |
| 2021-05-31 | 35.27M CAD 10-Q/A · filed 2021-08-02 |
| 2021-02-28 | 13.13M CAD 10-K · filed 2022-05-31 |